key: cord-0009690-uv277upv
authors: GOLDMAN, ARMOND S.; GOLDBLUM, RANDALL M.
title: Human Milk: Immunologic‐Nutritional Relationships
date: 1990-06-01
journal: Ann N Y Acad Sci
DOI: 10.1111/j.1749-6632.1990.tb00151.x
sha: 6acc0f88c0043831a37838ff72277013d18611be
doc_id: 9690
cord_uid: uv277upv

nan

The incidence and severity of certain bacterial and viral infections of the intestinal tract and respiratory system are significantly lower in breast-fed compared to non-breastfed infants '<" (TABLE 1). The protection provided by breast feeding includes a contraceptive effect and a lesser exposure of breast-fed infants to infectious agents (TABLE 2) . Even when the breast-fed infant ingests pathogenic bacteria during nursing, often no enteric symptoms develop. [3] [4] [5] These observations lead to the prediction that the protection afforded by human milk was due to antimicrobial agents in human milk. That prediction proved to be correct. 6 It is now recognized that the spectrum of protective agents in human milk includes not only preformed direct acting antimicrobial agents but also 1) agents created through limited digestion of substrates in milk, 2) antiinflammatory factors, and 3) immunostimulants (TABLE 2) .

The antimicrobial system in human milk consists of a complex group of biochemical agents. Although they differ widely in their structures, they commonly occur at other mucosal sites (TABLE 3) , persist throughout Iactation,"?" resist digestion in the alimentary tract, and protect by noninflammatory mechanisms.

Lactoferrin, a member of the transferrin family of iron-binding glycoproteins, has a Mr of about 80 kDa and two lobes, each of which contains a ferric iron binding site. 11 Lactoferrin is one of the most prominent whey proteins in human milk.?:"? Although most of the protein is intact, a 20-kDa fragment corresponding to half of the N lobe of the protein has recently been found in human milk. 12 About 80% of the iron-binding sites on human milk lactoferrin are unsaturated. The apoprotein competes with siderophilic bacteria for ferric iron and thus interferes with the multiplication of those microorganisms. 13 A great deal of the apoprotein is ingested by breast-fed mature infants during the first several months of life 10 ( of the ingested apoprotein persists throughout the alimentary tract,14-16 although an increase in the production of lactoferrin at the mucosal site of the infant is an alternative possibility. 15 In addition to the antimicrobial effects, lactoferrin may positively influence cell growth!" and negatively effect inflammation.P'"? Comparatively little is known, however, about the fate and functions of this factor in the recipient.

Lysozyme, a 12-kDa single chain protein, is found in relatively high concentrations in external secretions including human milk (TABLE 3) . Lysozyme lyses susceptible bacteria by hydrolyzing 13-1,4 linkages between N-acetylmuramic acid and 2acetylamino-2-deoxy-D-glucose residues in cell walls.r" Large amounts of this enzyme are provided to the infant by breast feeding.?"!" The agent is relatively resistant to digestion by trypsirr" or denaturation due to acid. 2 2 It was thus anticipated that this enzyme in human milk would persist in the gastrointestinal tract of the recipient infant. The amount oflysozyme that is excreted in the stools of human-milk-fed, low birth weight infants is in fact about eight times that in cow's-milk-fed infants. 15 Otherwise, the in vivo fate and functions of the agent remain to be determined.

Secretory IgA comprises over 90% of the immunoglobulin in human milk. 7 -1O This immunoglobulin is formed through two intricate processes. The first is the entero-bron- cho-mammary pathway for the migration of B lymphocytes that mature into polymeric IgA-producing plasma cells that populate the subepithelial zones. 23-26 The second is the binding of polymeric IgA to polymeric immunoglobulin receptors (membrane bound secretory component) located on the basolateral plasma membranes of epithelial cells of the mammary gland and the subsequent transport of polymeric IgA complexed with a major fragment of its receptor through the epithelial cell and secretion of the assembled complex into milk. 27,28 These processes may be regulated by hormones produced late in pregnancy or during lactanorr" and by cytokines. 29,30 The specificities of secretory IgA antibodies in human milk are a reflection of the enteric and respiratory antigens that trigger the migration of B lymphocytes into the entero-and broncho-mammary pathways. For example, a bacterial antigen taken up by M cells overlying Peyer's patches is recognized by B cells that bear specific antibodies against the antigen. Under the influence of interleukin 5, the isotype of the cell surface antibodies switches from IgM to IgA. These IgA-bearing B cells then enter afferent lymphatics and migrate sequentially to mesenteric lymph nodes, the cisterna chyli, thoracic duct, and systemic circulation and then home to the mammary gland where they undergo terminal maturation to plasma cells that produce polymeric IgA antibodies against the original eliciting antigen. Therefore, secretory IgA antibodies are directed against many important epitopes of enteric and respiratory pathogens. 31 Considerable amounts of these antibodies are ingested by the nursing infant particularly during the first months of complete breast feeding?"!" (FIG. I) . The amount of IgA which is excreted in the stools of low birth weight infants fed human milk is about 25-fold over that found in infants fed cow's milk preparations. 15 Furthermore, evidence is mounting that protection by breast feeding against enteric pathogens such as enteropathogenic Escherichiae coli or Vibrio cholerae is in large part due to specific secretory IgA antibodies in human milk. 32.33

Fibronectin, a high molecular weight protein that facilitates the uptake of many types of particulates by phagocytic cells, is present in human milk (mean concentrations in colostrum, 13.4 mg/L).34 next 2-3 months of milk production." Neutrophils and macrophages are the most prominent cells in human milk. Although human milk neutrophils are phagocytic, they are unable to adhere to common substrata, move as rapidly as neutrophils from venous blood,40-43 or respond to chemotactic agents.f" In contrast, macrophages in milk are far more motile than their counterparts, the blood monocytes." Human milk macrophages have also been found to produce toxic oxygen radicals'" and the protein products of the class I and II genes in the major histocompatibility complex." Lymphocytes are also found consistently in human milk. They are principally T cells and the relative frequencies of the major subsets of T cells (CD3 + 4 + and CD3 + 8 + cells) in human milk are similar to those in human blood. 46 The cytotoxic responses of these cells are poor,"? but the cells are capable of generating certain Iymphokines including interferon-v and monocyte chemotactic factor. 48 . 4 9 The in vivo role of these cells remains to be explored.

Human milk may also protect by supplying substrates that are partially digested in the recipient's alimentary tract to produce defense factors. Fatty acids and monoglycerides 240 ANNALS NEW YORK ACADEMY OF SCIENCES produced from milk fats by lipases in milk or from the recipient are able to disrupt enveloped viruses. 50.51 These antiviral lipids may aid in preventing coronavirus infections of the intestinal tract.52 They may also defend against intestinal parasites such as Giardia lambdia.t? Similar antimicrobial lipids are generated from fat found in cow's milk. The second example is the production of~-casomorphins from ingested human K-casein. 54 These peptide fragments have opioid effects;" but the agent has also been found to be an immunostimulant. 56 Fragments of human lactoferrin have also been demonstrated in the stools of human milk-fed infants. 15 A 20-kDa fragment of lactoferrin has been described in human milk, 12 but the multiplicity of fragments in the stools suggests that apolactoferrin from human milk feedings or produced in the alimentary tract is partially cleaved in the gastrointestinal tract of the recipient. Similar fragments of lactoferrin have been demonstrated in the urine of those infants'" suggesting that they originated from those produced in the gastrointestinal tract. The role of these fragments in those excreta is undetermined.

Finally, it is also possible that other immunologic factors are compartmentalized in human milk and are released during intestinal digestion. This is likely given the complex physical structure of human milk.

It has been known for many years that human milk contains growth promoters of the dominant resident bacteria in the lower intestinal tract of breast-fed infants.58 Certain oligosaccharides promote the growth of lactobacilli in the lower intestinal tract onne· infant. Acetic acid produced by those bacteria in turn inhibits the multiplication of bacterial pathogens such as E. coli, salmonella, or shigella.

One of the extraordinary features of the protection afforded by human milk is the virtual absence of clinical signs of inflammation during the process. This may be due in part to the more rapid elimination or neutralization of microbial pathogens by defense agents from human milk, but other features of human milk suggest that this is not the sole explanation. Phlogistic agents and the biochemical systems that give rise to them are poorly represented in human milk. 59.6O Moreover, human milk contains a host of antiinflammatory agents 59.6O (TABLE 4) . Some of these antiinflammatory agents, such as lactoferrin, secretory IgA, and lysozyme, double as antimicrobial factors. Like the antimicrobial factors, they are well adapted to operate in the hostile environment of the alimentary tract. In addition, two of the agents, o-tocopherol?' and~-carotene,62 are absorbed into the circulation where they may have systemic effects.

A number of experimental observations suggest that human milk actively as well as passively protects the recipient infant. Several reports claim that the production of IgA at mucosal sites is enhanced by human milk. 15.57.63-66 Although in most of those studies it has been difficult to exclude the effect of passively transferred secretory IgA, in two investigations the excretion of IgA was increased in the urinary tract, 57.66 a system far removed from direct contact with human milk. Furthermore, in one report the urinary excretion of secretory component was also remarkably increased in infants fed human milk. 57 Since the Mr of these proteins far exceeds the size of molecules filtered by glomeruli, and since neither secretory component nor secretory IgA are specifically transported from the systemic circulation into epithelial cells, it is most likely that human milk feedings stimulated the synthesis of secretory component by epithelial cells in the urinary tract and that this in turn enhanced the transport of secretory IgA into the urine of the infants. The components in human milk that may be responsible for such an enhancement are undetermined at this time.

The second piece of evidence is the response of breast-fed infants to respiratory syncytial virus (RSV).67 As compared to infants who were not breast fed, serum levels of interferon-a were strikingly increased in breast fed infants in the first 2-4 weeks after RSV infection. Since there is little interferon-a in human milk, it seems likely that human milk is able to prime leukocytes in the host to produce that cytokine. In addition, there is some evidence that the plasma concentrations of fibronectin appear to be higher in breastfed than non-breast-fed infants?" (237 and 17/mg/L, respectively). Since the amount of ingested firbonectin is not sufficient to account for the increment in plasma fibronectin that has been observed, it seems likely that human milk induces the synthesis of that oposonic protein in the infant.

If human milk stimulates certain defense systems in the infant, one might predict that the effects might lead to long lasting resistance. Supporting epidemiologic evidence for that premise has been mounting for the past several years. The incidence of juvenile diabetes mellitus appears to be less among children who have been breast fed during infancy.i" In addition, a recent retrospective analysis suggests that breast feeding lessens the risk from lymphomas.P? In each of these retrospective studies, considerable reliance has been placed upon the ability of mothers to recall the type and duration of feeding given to their offspring; yet recall of events that transpired many years beforehand may be suspect. Undoubtedly, prospective studies of the possible long-term protective role of human milk will be required to further explore the possible long-term immunologic benefits of human milk.

The last piece of evidence comes from the discovery of immunostimulators in human milk. It was previously noted that human milk contains a high concentration of atocopheral. In addition to its antioxidant effects, the vitamin is known to stimulate the development of immunity. 70-73 More recently it was reported that agents in the human milk activate the random motility of human monocytes. The discovery eminated from observations that macrophages from human milk are more motile than monocytes from human blood.F It was therefore predicted that human milk would contain chemokinetic agents for human monocytes. In subsequent investigations, it was found that the rate of movement of blood monocytes was increased by incubating them in human milk.?" The activators of monocytes were heat-sensitive, acid-resistant proteins. Three peaks of chemokinetic activity were found by column chromatography to correspond to 50-55, 20-25, and 15-20 kDa. Furthermore, the chemokinetic activities were significantly decreased by antibodies to one of the major monokines, tumor necrosis factor-a. The identity of these chemokinetic agents is still uncertain, but it is possible that one or more of the activators may be tumor necrosis factor-a, immunologically similar agents, or agents that stimulate the production of that cytokine.

Human milk emerges as a complex system of nutrients, some of which double as defense agents; preformed host defense agents that are comparatively resistant to digestion; defense agents produced by partial digestion of substrates from human milk; antiinflammatory factors; growth factors for protective microflora; and agents that speed the 242 ANNALS NEW YORK ACADEMY OF SCIENCES maturation of defense systems. The results of metabolic balance studies in breast-fed infants provide an insight into the ultimate fate of the members of the defense systems in human milk. It appears that the bulk of these lipids, carbohydrates, and proteins must be utilized to meet the nutritional requirements of the breast-fed infant. 75 Given the resistance of many of the components to digestive processes, it appears that the agents are not completely degraded until they reach the more distal regions of the alimentary tract, or after they are absorbed for systemic use. The precise ways in which these efficient defense systems in human milk operate in the recipient to directly fend off infections, minimize phlogistic reactions, or speed the maturation of the infant's defense systems should be the subject of intense study during the next decade. These investigations may well include the binding of defense agents to epithelial receptors, the consequences of receptor binding, the systemic absorption of certain components and their distribution and fate in the body, the site of and rate of digestion of the components, the specificity of the in vivo actions of the components directly upon microbial pathogens, the in vivo role of antiinflammatory agents, and the nature of and short-and long-term effects of immunologic stimulators upon the recipient.

Breast feeding and child health: Methodologic issues in epidemiologic research

Breast-feeding and morbidity in industrialized countries: An update

Diarrheal disease in a cohort of Guatemalan village children observed from birth to age two years

Shigella infection in breast-fed Guatemalan Indian neonates

Bacteria in colostrum and milk of Guatemalan Indian women

Host resistance factors in human milk

Immunologic factors in human milk during the first year of lactation

Immunologic components in human milk during the second year of lactation

Immunologic components in human milk during weaning

Daily ingestion of immunologic components in human milk during the first four months of life

Structure of human lactoferrin at 3.2-A resolution

Anti-bovine 13-lactoglobulin antibodies react with a human lactoferrin fragment and bovine 13-lactoglobulin present in human milk

Differences in inhibition of the growth of commensal and enteropathogenic strains of Escherichia coli by lactoferrin and secretory immunoglobulin A isolated from human milk

Characterization and properties of the human and bovine lactotransferrins extracted from the feces of newborn infants

Enhanced fecal excretion of selected immune factors in very low birth weight infants fed fortified human milk

The nutritional role of breast-milk IgA and lactoferrin

Human lactoferrin stimulates thymidine incorporation into DNA of rat crypt cells

Modulation of classical C3 convertase of complement tear lactoferrin

Human milk-derived lactoferrin inhibits mitogen and alloantigen induced human lymphocyte proliferation

Mechanism of lysozyme action

Human tear and human milk Iysozymes

Lysozymes in feces from infants and children

Hormonal induction of the secretory immune system in the mammary gland

Antibody-forming cells in human colostrum after oral immunization

Origin of IgA-secreting plasma cells in the mammary gland

Bronchomammary axis in the immune response to respiratory syncytial virus

A transmembrane precursor of secretory component. The receptor for transcellular transport of polymeric immunoglobulins

Biosynthesis of the IgA antibody receptor: A model for the transepithelial sorting of a membrane glycoprotein

Interferon-' Y enhances expressing of secretory component, the epithelial receptor for polymeric immunoglobulins

Tumor necrosis factor-a upregulates expression of secretory component of the epithelial recpetor for polymeric Ig

Immunoglobulins in human milk

Protection against cholera in breast-fed children by antibodies in breast milk

Breast milk anti-Escherichia coli heat-labile toxin IgA antibodies protect against toxin-induced infantile diarrhea

Plasma fibronectin concentrations in breasl fed and formula fed neonates

Nonimmunoglobulin fraction of 244 ANNALS NEW YORK ACADEMY OF SCIENCES human milk inhibits bacterial adhesion (hemagglutination) and enterotoxin binding of Escherichiae coli and Vibrio cholerae

Non-immunoglobulin fraction of human milk protects against enterotoxin-induced intestinal fluid secretion

Inhibition of enterotoxin from Escherichiae coli and Vibrio cholerae by gangliosides from human milk

Protection of suckling mice from the heat-stable enterotoxin of Escherichae coli by human milk

Inhibition of bacterial adhesion and toxin binding by glycoconjugate and oligosaccharide receptor analogues in human milk

Chemotaxis and random migration of human milk cells

Human milk cell migration and production of monocyte chemotactic factor: Lack of activity

Decreased response of human milk leukocytes to chemoattractant peptides

The motility of human milk macrophages in collagen gels

Oxygen metabolism of human colostral macrophages

Phenotype characterization and functional activity of human milk macrophages

T cell subsets in human colostrum

Human colostral cytotoxicity. I. Antibody-dependent cellular cytotoxicity against herpes simplex viral-infected cells mediated by colostral cells

Interferon production by lymphocytes in human milk

Lymphokine production by human milk leukocytes

Anti-infective properties of breast milk

Effect of antiviral lipids, heat, and freezing on the activity of viruses in human milk

Isolation and propogation of a human enteric coronavirus

Human milk kills parasitic protozoa

I3-Casomorphins: Do they have physiological significance? In Human Lactation 3. The Effects of Human Milk on the Recipient Infant

Novel opiod peptides derived from human l3-casein: human l3-casomorphins

Demonstration of l3-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestinal contents after bovine milk ingestion in adult humans

Human milk feeding enhances the urinary excretion of immunologic factors in low birth weight infants

Undialyzable growth factors for Lactobacillus bifidus var. Pennsylvanicus

Anti-inflammatory properties of human milk

Anti-inflammatory systems in human milk

Vitamin A and E content of human milk at early stages of lactation

Influence of breast-feeding on the restoration of the low serum concentration of vitamin E and~-carotene in the newborn infant

Immunoglobulins in preterm infants: Comparison of human milk and formula feedings

In-vivo immune responses of breast-and bottle-fed infants to tetanus toxoid antigen and to normal gut flora

Development of secretory immunity in breast fed and bottle fed infants

Breast feeding increases concentrations of IgA in infants' urine

Effect of breast feeding on responses of systemic interferon and virus-specific lymphocyte transformation in infants with respiratory syncytial virus infection

Reduced risk of insulin dependent diabetes mellitus (IODM) among breast fed children: A case control study

Infant feeding in childhood cancer

Vitamin E, immunity and disease resistance

Modulation of the immune system function of guinea pigs by dietary vitamins E and C following exposure to 100% 02

Interaction of dietary vitamin C and vitamin E on guinea pig immune responses to mitogens

Dietary vitamin E requirement for optimum immune responses in the rat

Chemokinetic agents for monocytes in human milk: Possible role of tumor necrosis factor-a

Special properties of human milk